Agreed and I am not surprised given the qualifications of the board - none have experience in medical devices.
Russo (Chairman) comes from Kmart.
Corlett comes from finance.
Gordon comes from furniture retail.
Flitcroft is a career company secretary.
Then you look at the co-CEOs. Blickstead has no experince in the medical devices. Borg on the other hand has had experience earlier in her career but she has been out of the industry for a while.
Is it any surprise that this board wasn't on top of the US reimbursement last year? Or that they weren't on top of the manufacturing this year?
Ann: Trading Halt, page-15
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $61.59M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $18.30K | 66.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 11380 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| SOM (ASX) Chart |